Glenn Copeland

531 total citations
15 papers, 385 citations indexed

About

Glenn Copeland is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Glenn Copeland has authored 15 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Glenn Copeland's work include Cervical Cancer and HPV Research (4 papers), BRCA gene mutations in cancer (3 papers) and Cancer Risks and Factors (3 papers). Glenn Copeland is often cited by papers focused on Cervical Cancer and HPV Research (4 papers), BRCA gene mutations in cancer (3 papers) and Cancer Risks and Factors (3 papers). Glenn Copeland collaborates with scholars based in United States, Switzerland and India. Glenn Copeland's co-authors include Beth Anderson, Mona Saraiya, Debra Duquette, Charles F. Lynch, Elizabeth Wasilevich, Sarah Lyon-Callo, Martin Steinau, Edward J. Wilkinson, Elizabeth R. Unger and Edward Peters and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and American Journal of Epidemiology.

In The Last Decade

Glenn Copeland

14 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn Copeland United States 11 168 150 103 82 78 15 385
Kate J. Krause United States 12 104 0.6× 141 0.9× 191 1.9× 61 0.7× 57 0.7× 37 526
Emilio Fonseca Brazil 14 75 0.4× 80 0.5× 204 2.0× 46 0.6× 56 0.7× 63 478
Anshuma Bansal India 8 106 0.6× 108 0.7× 73 0.7× 12 0.1× 46 0.6× 29 312
Karine Ligier France 12 82 0.5× 94 0.6× 105 1.0× 50 0.6× 117 1.5× 22 364
Cheng-I Liao Taiwan 10 213 1.3× 102 0.7× 120 1.2× 13 0.2× 29 0.4× 45 493
Hislop Tg Canada 10 101 0.6× 65 0.4× 209 2.0× 30 0.4× 16 0.2× 13 433
Chiara Borghi Italy 14 115 0.7× 213 1.4× 60 0.6× 28 0.3× 7 0.1× 36 495
Simon Leeson United Kingdom 13 392 2.3× 155 1.0× 160 1.6× 16 0.2× 13 0.2× 46 605
Laureen Ribassin-Majed France 8 97 0.6× 157 1.0× 145 1.4× 8 0.1× 187 2.4× 15 452
Ravi Kannan India 10 47 0.3× 198 1.3× 71 0.7× 25 0.3× 17 0.2× 31 326

Countries citing papers authored by Glenn Copeland

Since Specialization
Citations

This map shows the geographic impact of Glenn Copeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Copeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Copeland more than expected).

Fields of papers citing papers by Glenn Copeland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Copeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Copeland. The network helps show where Glenn Copeland may publish in the future.

Co-authorship network of co-authors of Glenn Copeland

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Copeland. A scholar is included among the top collaborators of Glenn Copeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Copeland. Glenn Copeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Laprise, Claudie, Elizabeth K. Cahoon, Charles F. Lynch, et al.. (2018). Risk of lip cancer after solid organ transplantation in the United States. American Journal of Transplantation. 19(1). 227–237. 20 indexed citations
2.
Copeland, Glenn, et al.. (2018). Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program. Breast Cancer Research and Treatment. 173(3). 693–699. 12 indexed citations
3.
Duquette, Debra, Meghan Underhill‐Blazey, Chang Ming, et al.. (2018). Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry. Breast Cancer Research and Treatment. 169(1). 141–152. 11 indexed citations
4.
Schraw, Jeremy M., Tania A. Desrosiers, Wendy N. Nembhard, et al.. (2018). Abstract LB-161: A population-based assessment of cancer risk among children with non-chromosomal birth defects in 10 million live births. Cancer Research. 78(13_Supplement). LB–161.
5.
Katapodi, Maria C., James J. Yang, Beth Anderson, et al.. (2017). Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study. Cancer Causes & Control. 28(3). 191–201. 16 indexed citations
6.
Dunietz, Galit Levi, Claudia Holzman, Yujia Zhang, et al.. (2017). Assisted reproduction and risk of preterm birth in singletons by infertility diagnoses and treatment modalities: a population-based study. Journal of Assisted Reproduction and Genetics. 34(11). 1529–1535. 13 indexed citations
7.
Potter, Rachel, Elaine W. Flagg, Samik Datta, Mona Saraiya, & Glenn Copeland. (2015). Monitoring the impact of human papillomavirus vaccines on high-grade pre-invasive cervical lesions: Designing a framework of linked immunization information system and cancer registry data in Michigan. Vaccine. 33(11). 1400–1405. 7 indexed citations
8.
Goodman, Marc T., Mona Saraiya, Trevor Thompson, et al.. (2015). Human papillomavirus genotype and oropharynx cancer survival in the United States of America. European Journal of Cancer. 51(18). 2759–2767. 73 indexed citations
9.
Coghill, Anna E., Meredith S. Shiels, Glenn Copeland, et al.. (2015). Rectal squamous cell carcinoma in immunosuppressed populations. AIDS. 30(1). 105–112. 21 indexed citations
10.
Hernandez, Brenda Y., Marc T. Goodman, Elizabeth R. Unger, et al.. (2014). Human Papillomavirus Genotype Prevalence in Invasive Penile Cancers from a Registry-Based United States Population. Frontiers in Oncology. 4. 9–9. 40 indexed citations
11.
Gargano, Julia W., Edward J. Wilkinson, Elizabeth R. Unger, et al.. (2012). Prevalence of Human Papillomavirus Types in Invasive Vulvar Cancers and Vulvar Intraepithelial Neoplasia 3 in the United States Before Vaccine Introduction. Journal of Lower Genital Tract Disease. 16(4). 471–479. 56 indexed citations
12.
Anderson, Beth, et al.. (2012). Barriers and Facilitators for Utilization of Genetic Counseling and Risk Assessment Services in Young Female Breast Cancer Survivors. SHILAP Revista de lepidopterología. 2012. 1–11. 70 indexed citations
13.
Hirsch, Jennifer C., Glenn Copeland, Janet E. Donohue, et al.. (2011). Population-Based Analysis of Survival for Hypoplastic Left Heart Syndrome. The Journal of Pediatrics. 159(1). 57–63. 41 indexed citations
14.
Copeland, Glenn. (2010). The role of public health and how boundary analysis can provide a tool for public health investigations: The public health perspective. Spatial and Spatio-temporal Epidemiology. 1(4). 201–205. 1 indexed citations
15.
Nechuta, Sarah, Nigel Paneth, Dorothy R. Pathak, et al.. (2010). A Population-based Case-Control Study of Fetal Growth, Gestational Age, and Maternal Breast Cancer. American Journal of Epidemiology. 172(8). 962–970. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026